"Researchers at a consortium of European labs have weaponised a biological quirk: pig semen contains naturally occurring nanoparticles small enough to cross the blood-brain barrier and other immunological gatekeepers that render most cancer drugs useless once they reach the bloodstream."

"The blood-brain barrier stops 99% of large-molecule drugs from reaching the brain, making Alzheimer's, glioblastoma, and other CNS cancers nearly untreatable with conventional chemotherapy."

"This discovery matters because it solves a 30-year-old problem that has cost the pharmaceutical industry hundreds of billions in failed drug programmes."

"Scientists have used pig semen to develop eye drops that can stop tumour growth in the retina and preserve vision, a study in mice shows. The work is published today in Science Advances. It is hoped that the drops could be developed to treat children with retinoblastoma, a cancer of the retina. The condition is typically treated with injections of drugs into the eye, chemotherapy or laser therapy, all of which can damage non-cancerous parts of the eye."

"The team used exosomes derived from semen because the particles enable sperm to penetrate the female reproductive tract. In studies with human corneal cells, the researchers determined that the exosomes from pig semen can open and close tight junctions — semipermeable structures found in the external membrane of the cells on the surface of the eye. To improve the exosomes' selectivity, the team attached them to folic acid molecules. Retinoblastoma cells have much higher levels of folic acid than healthy cells do."

"The exosomes successfully penetrated the retinal barrier in mice, a feat that failed when the active compounds were applied unpackaged."

"Folic acid attachment targets the exosomes to cancer cells preferentially, reducing off-target toxicity."

"The technique could improve drug delivery across other barriers that are similarly difficult to breach, such as the blood–brain barrier — to treat conditions including Alzheimer's disease — or the mucosal barrier"

"Pig semen is not the point. The source material is incidental. What matters is that these particles—derived from boar seminal plasma—possess a natural coating that evades immune recognition and crosses epithelial barriers without triggering inflammation."

"The competitive advantage flows to whoever controls manufacturing and intellectual property."

"Retinoblastoma affects approximately 3,000 children globally each year, with cure rates exceeding 95% in high-income countries but dropping below 50% in low-income regions."

"Current therapies preserve sight in roughly 75–80% of cases but carry significant morbidity — systemic chemotherapy toxicity, retinal scarring from laser therapy, and the procedural trauma of repeated intraocular injections."

"Whoever masters synthesis or fermentation-based production first captures the market. China's biotech sector is already mobilising."